Prevention of Hepatitis C Virus (HCV) and HIV-1 Co-Infections
A collaborative project financed by the EC Framework Programme 7
T cell immunity to viral pathogens is a major focus of this research. Oxford University has made significant investment in "bench to bedside" vaccine research over the last 15 years, with the establishment of the Centre for Clinical Vaccinology, the Jenner Institute and a clinical biomanufacturing facility.
Research groups contributing to PEACHI are based at the Nuffield Department of Medicine Research Building, the Peter Medawar Building for Pathogen Research and the Jenner Institute.
The Medical Sciences Division is internationally recognised for excellence in biomedical research, particularly in Infection and Immunity.
Ellie Barnes is a MRC research fellow and a Honory Consultant in Hepatology at the Nuffield Department of Medicine, University of Oxford. Her research interests are vaccine development and immunology. One of her main aims is to develop an effective HCV vaccine, and she leads the PEACHI03 team.
Lucy Dorrell is a Senior Clinical Research Fellow at the Nuffield Department of Medicine, University of Oxford, and a Honorary Consultant in GUM/HIV. Her research interests lie in immunology and infectious diseases. She is the lead investigator on the PEACHI grant.